Authors: David Vodušek
The European Academy of Neurology (EAN) held its 1st Congress in Berlin, Germany, from the 20th to 23rd June 2015. The EAN was formed last year following a merger between the European Federation of Neurological Societies and the European Neurological Society. The new society, unifying all European neurologists, hopes to be well placed to make major contributions to neurological health care in Europe; including playing a coordinating role in education and training in neurology, in neurological practice, and in defining uniform diagnostic and therapeutic standards for patient care. The EAN is also aiming to promote scientific research in neurology as well as the neurosciences in general as it becomes increasingly obvious that neurological diseases have major public health relevance.
More than 220 million people in Europe (1) suffer from some form of neurological disease and the incidence of many conditions such as Alzheimer’s and stroke will further increase in an aging society – a ticking time bomb for health care systems. This scale and impact of neurological disease in Europe is underestimated and often overlooked, and was an important health care policy message that came out of the 1st Congress of the European Academy of Neurology where 6,400 experts from across the globe gathered.
Scientific presentations at the congress covered the whole spectrum of neurology and there were several topical highlights; some recent trends and news in the fields of stroke, multiple sclerosis (MS) and epilepsy are presented.